Table 3 Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between invasive breast cancer and mean exposure to PM2.5 and PM10a by grade of differentiation, stage, histology subtype and hormone receptor status of the tumor.
PM2.5 mean exposure | PM10 mean exposure | ||
|---|---|---|---|
Matched cases/controlsb | Adjusted ORc (95% CI) | Adjusted ORc (95% CI) | |
Grade | |||
Grade 1 | 614/614 | 1.24 (0.84–1.83) | 1.14 (0.89–1.48) |
Grade 2 | 1483/1483 | 1.01 (0.78–1.30) | 0.98 (0.84–1.16) |
Grade 3 | 2067/2067 | 1.09 (0.87–1.35) | 1.09 (0.94–1.26) |
Stage | |||
Stage I | 2919/2919 | 1.24 (1.03–1.49) | 1.15 (1.02–1.30) |
Stage II | 1412/1412 | 1.10 (0.85–1.42) | 1.05 (0.89–1.25) |
Stage III and Stage IVd | 402/402 | 0.76 (0.47–1.22) | 0.82 (0.60–1.11) |
Histology subtypes | |||
Invasive ductal | 3568/3568 | 1.15 (0.97–1.36) | 1.09 (0.97–1.22) |
Invasive lobular | 828/828 | 0.92 (0.66-1.27) | 0.91 (0.73–1.14) |
Invasive tubular | 141/141 | 1.07 (0.48–2.37) | 1.15 (0.66–2.00) |
Invasive ductal and lobular | 123/123 | 2.74 (1.05–7.15) | 2.05 (1.11–3.78) |
Hormone receptor status | |||
ER+ | 3405/3405 | 1.17 (0.98–1.39) | 1.08 (0.96–1.21) |
ER- | 760/760 | 1.04 (0.71–1.51) | 1.06 (0.82–1.35) |
PR+ | 2602/2602 | 1.15 (0.94–1.40) | 1.06 (0.92–1.21) |
PR- | 1439/1439 | 1.07 (0.82–1.39) | 1.04 (0.88–1.24) |
ER + /PR+ | 2459/2459 | 1.13 (0.92–1.39) | 1.04 (0.91–1.20) |
ER-/PR- | 612/612 | 0.90 (0.59–1.38) | 0.97 (0.73–1.28) |
ER + /PR- | 825/825 | 1.18 (0.84–1.65) | 1.08 (0.87–1.36) |
ER-/PR+ | 140/140 | 1.48 (0.63–3.52) | 1.32 (0.75–2.32) |